Metallothioneins in Biochemistry and Pathology 2008
DOI: 10.1142/9789812778949_0014
|View full text |Cite
|
Sign up to set email alerts
|

Metallothioneins and Liver Diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 32 publications
1
3
0
Order By: Relevance
“…On the pathway level, multiple genesets pointed to a reduced level plasma lipoprotein particle assembly and remodelling which indicates changes in lipid distribution. This aligns with the known dyslipidaemia in chronic liver diseases, including decreasing serum values of LDL, HDL, total cholesterol, and triglycerides with increasing severity of disease, based on which previous studies suggested that routine monitoring of lipid profiles can improve the outcome for CLD patients [70] Furthermore, a down-regulation of response to metal ions was found which could be related to to metallothioneins which protect against oxidative stress and are able to chelate heavy metals [71].…”
Section: Time-concordant Events Reflecting Disease Progressionsupporting
confidence: 69%
See 1 more Smart Citation
“…On the pathway level, multiple genesets pointed to a reduced level plasma lipoprotein particle assembly and remodelling which indicates changes in lipid distribution. This aligns with the known dyslipidaemia in chronic liver diseases, including decreasing serum values of LDL, HDL, total cholesterol, and triglycerides with increasing severity of disease, based on which previous studies suggested that routine monitoring of lipid profiles can improve the outcome for CLD patients [70] Furthermore, a down-regulation of response to metal ions was found which could be related to to metallothioneins which protect against oxidative stress and are able to chelate heavy metals [71].…”
Section: Time-concordant Events Reflecting Disease Progressionsupporting
confidence: 69%
“…Furthermore, a down-regulation of response to metal ions was found which could be related to metallothioneins which protect against oxidative stress and are able to chelate heavy metals [52].…”
Section: Time-concordant Events Reflecting Disease Progressionmentioning
confidence: 99%
“…This aligns with the known dyslipidaemia in chronic liver diseases, including decreasing serum values of LDL, HDL, total cholesterol, and triglycerides with increasing severity of disease, based on which previous studies suggested that routine monitoring of lipid profiles can improve the outcome for CLD patients [ 70 ]. Furthermore, a down-regulation of response to metal ions was found which could be related to metallothioneins which protect against oxidative stress and are able to chelate heavy metals [ 71 ]. Both directions of dysregulation were previously observed in liver diseases: While a negative correlation with disease progression was found in hepatocellular carcinoma [ 72 ], a positive correlation was found in most other liver diseases including acetaminophen-induced liver injury [ 73 ].…”
Section: Resultsmentioning
confidence: 99%
“…In MT1, there existed MT1A, MT1B, MT1E, MT1F, MT1G, MT1H, MT1M, and MT1X isoforms ( 49 ). These proteins mainly regulated copper and zinc homeostasis in the liver and protected hepatocytes from oxidative damage ( 50 ). Thus, MT1 expression negatively correlated with the damage status of chronic liver diseases ( 51 ).…”
Section: Discussionmentioning
confidence: 99%